Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

3.9K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.9K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

454
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
454
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

15.3K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
15.3K
Nursing Assessment of the Genitourinary System I: Health History01:21

Nursing Assessment of the Genitourinary System I: Health History

312
The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
312
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

194
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
194
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

381
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
381

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Memorable dates and anniversaries in the history of urology and related specialities in 2023. Part 2].

Urologiia (Moscow, Russia : 1999)·2023
Same author

[Modern algorithm of diagnosis and treatment of acute gestational pyelonephritis in a large industrial city].

Urologiia (Moscow, Russia : 1999)·2022
Same author

[Urological complications of N.A. Nekrasovs disease].

Urologiia (Moscow, Russia : 1999)·2022
Same author

[Phenazopyridine and fosfomycin for the acute cystitis treatment: results of multicenter randomized study].

Urologiia (Moscow, Russia : 1999)·2021
Same author

[Foreign body in the urinary bladder intrauterine device].

Urologiia (Moscow, Russia : 1999)·2021
Same author

[Treatment of acute uncomplicated cystitis in women with antibiotic allergy or intolerance].

Urologiia (Moscow, Russia : 1999)·2019

Related Experiment Video

Updated: Dec 26, 2025

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

681

[Sexual dysfunction in patients with chronic prostatitis and its treatment].

M I Davidov1

  • 1FGBOU VO Academician Ye. A. Vagner Perm State Medical University of the Ministry of Healthcare of the Russian Federation, Perm, Russia.

Urologiia (Moscow, Russia : 1999)
|March 20, 2020
PubMed
Summary

Sexual disorders like premature ejaculation are common in chronic prostatitis (CP). A combination of Vitaprost and NeuroDose effectively treated these dysfunctions in 94.3% of patients, improving sexual function and quality of life.

Keywords:
NeuroDoseVitaprostchronic prostatitispremature ejaculationsexual dysfunctiontreatment

More Related Videos

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.8K
Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
09:49

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation

Published on: August 13, 2015

9.6K

Related Experiment Videos

Last Updated: Dec 26, 2025

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

681
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.8K
Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
09:49

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation

Published on: August 13, 2015

9.6K

Area of Science:

  • Urology
  • Andrology
  • Sexual Medicine

Background:

  • Chronic prostatitis (CP) frequently leads to sexual disorders.
  • Common sexual dysfunctions include premature ejaculation and decreased orgasm intensity.

Purpose of the Study:

  • To determine the prevalence and types of sexual disorders in CP patients.
  • To assess the efficacy of Vitaprost and NeuroDose in treating these sexual dysfunctions.

Main Methods:

  • A two-stage study involving 422 CP patients.
  • Utilized questionnaires (Loran-Segal, IIEF-5) and clinical assessments.
  • Second stage involved 244 patients treated with Vitaprost and NeuroDose for two months.

Main Results:

  • Sexual disorders were present in 77% of CP patients, primarily premature ejaculation and decreased orgasm intensity.
  • Vitaprost and NeuroDose therapy resulted in a 94.3% effectiveness rate.
  • Significant improvements observed in male copulative function, sexual intercourse duration, orgasm intensity, and reduced neuropsychiatric symptoms.

Conclusions:

  • Premature ejaculation and decreased orgasm intensity are prevalent in CP.
  • Combination therapy with Vitaprost and NeuroDose demonstrates high efficacy for treating sexual dysfunction in CP patients.